Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Rudd

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Seminars in Immunology|October 13, 2019
Advances in T-cell co-receptor biology and cancer immunotherapyChristopher E Rudd
Seminars in Immunopathology|March 19, 2010
T-cell signaling and immunopathologiesChristopher E Rudd
Frontiers in Cell and Developmental Biology|April 1, 2021
How the Discovery of the CD4/CD8-p56<sup>lck</sup> Complexes Changed Immunology and ImmunotherapyChristopher E Rudd
European Journal of Immunology|March 14, 2009
CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsetsChristopher E Rudd
Frontiers in Pharmacology|January 4, 2021
Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case ReportChristopher E Rudd
Nature Immunology|January 3, 2024
Stuart Schlossman (1935-2023)Christopher E Rudd
Nature Immunology|March 24, 2005
MAPK p38: alternative and nonstressful in T cellsChristopher E Rudd
The New England Journal of Medicine|May 5, 2006
Disabled receptor signaling and new primary immunodeficiency disordersChristopher E Rudd
Science Immunology|January 5, 2020
A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockadeChristopher E Rudd
Nature Cancer|August 3, 2023
CD8<sup>+</sup> T cell killing of MHC class I-deficient tumorsChristopher E Rudd
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Immunology|October 13, 2019
Advances in T-cell co-receptor biology and cancer immunotherapyChristopher E Rudd
Seminars in Immunopathology|March 19, 2010
T-cell signaling and immunopathologiesChristopher E Rudd
Frontiers in Cell and Developmental Biology|April 1, 2021
How the Discovery of the CD4/CD8-p56<sup>lck</sup> Complexes Changed Immunology and ImmunotherapyChristopher E Rudd
European Journal of Immunology|March 14, 2009
CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsetsChristopher E Rudd
Frontiers in Pharmacology|January 4, 2021
Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case ReportChristopher E Rudd
Nature Immunology|January 3, 2024
Stuart Schlossman (1935-2023)Christopher E Rudd
Nature Immunology|March 24, 2005
MAPK p38: alternative and nonstressful in T cellsChristopher E Rudd
The New England Journal of Medicine|May 5, 2006
Disabled receptor signaling and new primary immunodeficiency disordersChristopher E Rudd
Science Immunology|January 5, 2020
A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockadeChristopher E Rudd
Nature Cancer|August 3, 2023
CD8<sup>+</sup> T cell killing of MHC class I-deficient tumorsChristopher E Rudd
Pageof 12